P2Y12R was also shown to enhance withstanding chemotherapy-induced cytotoxic stress in breast cancer [82], while the P2Y12R antagonism was shown to reduce pancreatic tumor growth in synergism with chemotherapeutic agents [30]. This evidence concerns the gene P2RY12 and pancreatic neoplasm.